Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), INF 581, D-69120 Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), INF 460, D-69120 Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), INF 280, D-69120 Heidelberg, Germany.
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), INF 581, D-69120 Heidelberg, Germany.
J Clin Epidemiol. 2016 Feb;70:224-32. doi: 10.1016/j.jclinepi.2015.09.017. Epub 2015 Oct 9.
Monitoring cancer survival is a key task of cancer registries, but timely disclosure of progress in long-term survival remains a challenge. We introduce and evaluate a novel method, denoted "boomerang method," for deriving more up-to-date estimates of long-term survival.
We applied three established methods (cohort, complete, and period analysis) and the boomerang method to derive up-to-date 10-year relative survival of patients diagnosed with common solid cancers and hematological malignancies in the United States. Using the Surveillance, Epidemiology and End Results 9 database, we compared the most up-to-date age-specific estimates that might have been obtained with the database including patients diagnosed up to 2001 with 10-year survival later observed for patients diagnosed in 1997-2001.
For cancers with little or no increase in survival over time, the various estimates of 10-year relative survival potentially available by the end of 2001 were generally rather similar. For malignancies with strongly increasing survival over time, including breast and prostate cancer and all hematological malignancies, the boomerang method provided estimates that were closest to later observed 10-year relative survival in 23 of the 34 groups assessed.
The boomerang method can substantially improve up-to-dateness of long-term cancer survival estimates in times of ongoing improvement in prognosis.
监测癌症生存情况是癌症登记处的一项主要任务,但及时公布长期生存方面的进展仍然是一个挑战。我们介绍并评估了一种新的方法,称为“回旋镖法”,用于推导出更接近当前的长期生存估计值。
我们应用了三种已确立的方法(队列、完整和时期分析)和回旋镖法,以推导出美国常见实体癌和血液恶性肿瘤患者的最新 10 年相对生存率。使用监测、流行病学和最终结果 9 数据库,我们将可能通过包括截至 2001 年诊断的患者的数据库获得的最新年龄特异性估计值与 1997-2001 年诊断的患者后来观察到的 10 年生存率进行了比较。
对于生存时间没有或几乎没有增加的癌症,到 2001 年底可能获得的各种 10 年相对生存率估计值通常非常相似。对于随着时间的推移生存能力显著提高的恶性肿瘤,包括乳腺癌和前列腺癌以及所有血液恶性肿瘤,回旋镖法在 34 个评估组中的 23 个提供了最接近后来观察到的 10 年相对生存率的估计值。
在预后不断改善的情况下,回旋镖法可以大大提高长期癌症生存估计值的及时性。